|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to wholesale importation of prescription drugs for resale |
|
to Texas residents. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. SHORT TITLE. This Act shall be known as the |
|
"Wholesale Prescription Drug Importation Act." |
|
SECTION 2. WHOLESALE PRESCRIPTION DRUG IMPORTATION |
|
PROGRAM. Subtitle C, Title 2, Health and Safety Code is amended by |
|
adding Chapter 66 to read as follows: |
|
CHAPTER 66. WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM |
|
SUBCHAPTER A. GENERAL PROVISIONS. |
|
Sec. 66.001. DEFINITIONS. In this chapter: |
|
(1) "Canadian supplier" means a manufacturer, wholesale |
|
distributor or pharmacy that is appropriately licensed or permitted |
|
under Canadian federal or provincial laws and rules to manufacture, |
|
distribute or dispense prescription drugs. |
|
(2) "Commission" means Health and Human Services |
|
Commission. |
|
(3) "Eligible prescription drug" means a drug eligible for |
|
importation that: |
|
(a) meets the United States federal food and drug |
|
administration's standards related to safety, effectiveness, |
|
misbranding and adulteration; |
|
(b) does not violate federal patent laws; |
|
(c) is expected to generate cost savings; and |
|
(d) is not a controlled substance; |
|
(4) "Program" means the wholesale prescription drug |
|
importation program; and |
|
(5) "State drug wholesaler" means a licensed wholesale drug |
|
distributor that contracts with the state to import eligible |
|
prescription drugs from a Canadian supplier. |
|
Sec. 66.002. CONSTRUCTION OF CHAPTER; PURPOSE. (a) The |
|
purpose of this chapter is to establish a program to make |
|
prescription drugs that are available at lower costs outside the |
|
United States available to consumers in Texas at those lower costs. |
|
Sec. 66.003. ESTABLISHMENT OF WHOLESALE PRESCRIPTION DRUG |
|
IMPORTATION PROGRAM. (a) The commission shall design a "wholesale |
|
prescription drug importation program" that complies with the |
|
applicable requirements of 21 U.S.C. Section 384, including the |
|
requirements regarding safety and cost savings. The commission |
|
shall explore all potential mechanisms, to the extent allowable |
|
under law, for the importation of eligible prescription drugs. The |
|
program design shall: |
|
(1) contract with one or more state drug wholesalers |
|
to seek federal certification and approval to import safe, eligible |
|
prescription drugs from Canadian suppliers and provide significant |
|
prescription drug cost savings to Texas consumers; |
|
(2) allow the importation of eligible prescription |
|
drugs sold by Canadian suppliers; |
|
(3) ensure that only eligible prescription drugs |
|
meeting the United States food and drug administration's safety, |
|
effectiveness and other standards are imported by or on behalf of |
|
the state; |
|
(4) import only those eligible prescription drugs |
|
expected to generate substantial savings for Texas consumers; |
|
(5) ensure that, with respect to eligible prescription |
|
drugs to be imported pursuant to the program, the program and the |
|
state drug wholesaler comply with the tracking, tracing, |
|
verification and identification requirements of 21 U.S.C. Sections |
|
360eee and 360eee-1; |
|
(6) prohibit the distribution, dispensing or sale of |
|
eligible prescription drugs imported pursuant to the Wholesale |
|
Prescription Drug Importation Act outside the exterior boundaries |
|
of the state; |
|
(7) recommend a charge per prescription or another |
|
method of support to ensure that the program is funded adequately in |
|
a manner that does not jeopardize significant consumer savings; and |
|
(8) include an audit function. |
|
Sec. 66.004. MONITORING FOR ANTI-COMPETITIVE |
|
BEHAVIOR. (a) The commission shall consult with the attorney |
|
general to identify the potential, and to monitor, for |
|
anti-competitive behavior in industries that would be affected by |
|
the program. |
|
Sec. 66.005. FEDERAL COMPLIANCE. (a) The commission shall |
|
submit a formal request to the secretary of the United States |
|
department of health and human services for certification of the |
|
state's program. |
|
Sec. 66.006. IMPLEMENTATION. (a) Upon certification of |
|
approval by the secretary of the United States department of health |
|
and human services, the commission shall begin implementing the |
|
program and begin operating the program within six months of that |
|
approval. As part of the implementation process, the commission |
|
shall: |
|
(1) enter into contracts in accordance with the |
|
Procurement Code with one or more state drug wholesalers and Texas |
|
licensed drug distributors and contract with one or more approved |
|
Canadian suppliers; |
|
(2) consult with interested stakeholders, including |
|
the committee, the legislature, health insurance plans, employers, |
|
pharmacies, health care providers and consumers; |
|
(3) develop a registration process for health |
|
insurance plans, pharmacies and prescription drug administering |
|
health care providers who choose to participate in the program; |
|
(4) make a list of imported eligible prescription |
|
drugs and their prices and make that list available to all |
|
participating entities and the general public; |
|
(5) create an outreach and marketing plan to generate |
|
program awareness; |
|
(6) create and staff a helpline to answer questions |
|
and address the needs of consumers, employers, health insurance |
|
plans, pharmacies, health care providers and other affected |
|
sectors; |
|
(7) require annual specific audits of the program; and |
|
(8) carry out other duties in accordance with the |
|
Wholesale Prescription Drug Importation Act that the commission |
|
determines to be necessary for successful implementation of the |
|
program. |
|
Sec. 66.007. ANNUAL REPORTING. (a) Annually, after |
|
implementation, the commission shall report to the governor and the |
|
legislature regarding the operation of the program during the |
|
previous year, including: |
|
(1) which eligible prescription drugs and Canadian |
|
suppliers are included in the program; |
|
(2) the number of participating pharmacies, health |
|
care providers and health insurance plans; |
|
(3) the number of prescriptions dispensed through the |
|
program; |
|
(4) the estimated savings to consumers, health plans, |
|
employers and the state during the previous year and to date; |
|
(5) information regarding implementation of the audit |
|
plan and the correction plans for audit findings; and |
|
(6) any other information requested by the governor or |
|
the legislature or state health authority deems relevant. |
|
Sec. 66.008. COUNTRIES OTHER THAN CANADA ALLOWED BY FEDERAL |
|
LAW. (a) The provisions of the Wholesale Prescription Drug |
|
Importation Act may be extended to any other country allowed by |
|
federal law to import prescription drugs into the United States, at |
|
the discretion of the commission. |
|
SECTION 3. As soon as practicable after the effective date |
|
of this Act, the executive commissioner of the Health and Human |
|
Services Commission and any other state agency designated by the |
|
executive commissioner shall adopt rules necessary to implement |
|
Chapter 66, Health and Safety Code, as added by this Act. |
|
SECTION 4. This Act takes effect September 1, 2023. |